Trial Profile
Effect of Proton Pump Inhibitor on Gastric Emptying and Satiety Function in Patients With Functional Dyspepsia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- Acronyms BreathID-PPI
- 30 Jan 2019 Status changed from recruiting to completed.
- 18 Feb 2011 Planned End Date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 14 Jan 2010 Actual initiation date (Dec 2009) added as reported by ClinicalTrials.gov.